Canada markets open in 1 hour 59 minutes

Corvus Pharmaceuticals Inc (C17.SG)

Stuttgart - Stuttgart Delayed Price. Currency in EUR
Add to watchlist
1.9340-0.0810 (-4.02%)
As of 08:07AM CEST. Market open.
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Total Revenue
0
0
0
0
0
-
Operating Expenses
Research Development
16,007
16,526
24,468
29,115
31,830
-
Selling General and Administrative
7,079
6,881
8,097
9,515
11,930
-
Total Operating Expenses
23,086
23,407
32,565
38,630
43,760
-
Operating Income or Loss
-23,086
-23,407
-32,565
-38,630
-43,760
-
Interest Expense
-
-
-
15
-
-
Total Other Income/Expenses Net
-3,295
-5,206
-9,396
-4,596
37,225
-
Income Before Tax
-24,857
-27,029
-41,307
-43,241
-5,995
-
Income from Continuing Operations
-24,857
-27,029
-41,307
-43,241
-5,995
-
Net Income
-24,857
-27,029
-41,307
-43,241
-5,995
-
Net Income available to common shareholders
-24,857
-27,029
-41,307
-43,241
-5,995
-
Basic EPS
-0.64
-
-0.89
-1.03
-0.20
-1.59
Diluted EPS
-0.64
-
-0.89
-1.03
-0.20
-1.59
Basic Average Shares
47,401
-
46,554
41,854
29,479
29,350
Diluted Average Shares
47,401
-
46,554
41,854
29,479
29,350